Emanuel Bottino1, Andrés Alberto Ponce2. 1. Cátedra de Fisiología Humana, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba. bottinoemma@gmail.com. 2. Cátedra de Fisiología Humana, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba . andresaponce@hotmail.com.
Abstract
Introduction: The emerging infection caused by the new SARS-CoV-2 coronavirus has become a real challenge for the scientific community. Currently, there is little knowledge about the pathogenesis of COVID-19 and in recent times the participation of the host's own immune response in the progression of the disease has been proposed. Innate pulmonary immunity is the first barrier against different toxins, which can cause tissue damage, with the consequent alteration of respiratory function. However, a loss in the regulation of these inflammatory mechanisms can cause a disruption in the homeostasis of the affected tissue. Objective: To evaluate the role of the pulmonary innate immune response in the pathogenesis of COVID-19. : Results: A global alteration of the pulmonary innate immune response was found in SARS-CoV-2 infection, which would have relevance in the pathogenesis of COVID-19. Materials and methods: A systematic review of studies published in scientific search engines was carried out: PubMed, Google Scholar, Science Direct. The following keywords were used: “COVID-19”; "Acute Respiratory Distress Syndrome"; "SARS-CoV-2"; "Innate pulmonary immunity"; "Innate immune response". Conclusion: The global involvement of the innate immune response and consequently of lung tissue homeostasis, in SARS-CoV-2 infection, requires the design of new therapeutic strategies aimed at modulating the altered pro-inflammatory mechanisms in COVID-19. Universidad Nacional de Córdoba.
Introduction: The emerging infection caused by the new SARS-CoV-2 coronavirus has become a real challenge for the scientific community. Currently, there is little knowledge about the pathogenesis of COVID-19 and in recent times the participation of the host's own immune response in the progression of the disease has been proposed. Innate pulmonary immunity is the first barrier against different toxins, which can cause tissue damage, with the consequent alteration of respiratory function. However, a loss in the regulation of these inflammatory mechanisms can cause a disruption in the homeostasis of the affected tissue. Objective: To evaluate the role of the pulmonary innate immune response in the pathogenesis of COVID-19. : Results: A global alteration of the pulmonary innate immune response was found in SARS-CoV-2 infection, which would have relevance in the pathogenesis of COVID-19. Materials and methods: A systematic review of studies published in scientific search engines was carried out: PubMed, Google Scholar, Science Direct. The following keywords were used: “COVID-19”; "Acute Respiratory Distress Syndrome"; "SARS-CoV-2"; "Innate pulmonary immunity"; "Innate immune response". Conclusion: The global involvement of the innate immune response and consequently of lung tissue homeostasis, in SARS-CoV-2 infection, requires the design of new therapeutic strategies aimed at modulating the altered pro-inflammatory mechanisms in COVID-19. Universidad Nacional de Córdoba.
Authors: Basak B Ural; Stephen T Yeung; Payal Damani-Yokota; Joseph C Devlin; Maren de Vries; Paola Vera-Licona; Tasleem Samji; Catherine M Sawai; Geunhyo Jang; Oriana A Perez; Quynh Pham; Leigh Maher; P'ng Loke; Meike Dittmann; Boris Reizis; Kamal M Khanna Journal: Sci Immunol Date: 2020-03-27
Authors: Dario Bongiovanni; Melissa Klug; Olga Lazareva; Simon Weidlich; Marina Biasi; Simona Ursu; Sarah Warth; Christian Buske; Marina Lukas; Christoph D Spinner; Moritz von Scheidt; Gianluigi Condorelli; Jan Baumbach; Karl-Ludwig Laugwitz; Markus List; Isabell Bernlochner Journal: Cell Death Dis Date: 2021-01-05 Impact factor: 8.469
Authors: Louise Dalskov; Michelle Møhlenberg; Jacob Thyrsted; Julia Blay-Cadanet; Ebbe Toftgaard Poulsen; Birgitte Holst Folkersen; Søren Helbo Skaarup; David Olagnier; Line Reinert; Jan Johannes Enghild; Hans Jürgen Hoffmann; Christian Kanstrup Holm; Rune Hartmann Journal: EMBO Rep Date: 2020-10-28 Impact factor: 9.071